STROKE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138685, encodeId=ce862138685a0, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：Stroke 经验分享：卒中学顶级期刊，官网称15天左右给出第一决定，从递交到正式接受约140天，50%的投稿被直接Desk Reject，最终的接受率约10%，含金量极高的杂志，国人投稿比例居于第三，相对友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue May 23 22:21:18 CST 2023, time=2023-05-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=568794, encodeId=d16b568e9482, content=投了一篇meta，要求润色，请问润色后被接受的概率大吗？可以自己润色不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1832, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=222a2577847, createdName=2018b066_47191297, createdTime=Fri Mar 29 10:35:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201537, encodeId=6fd2220153e81, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿一个月后给的返修建议。想问下有没有人在修稿时加过作者啊？想咨询一下流程~顺便想问下所有作者确认的邮件链是啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42ae8186426, createdName=ms7000001088510634, createdTime=Fri May 03 08:55:41 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156952, encodeId=35d321569521c, content=审稿速度:1.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af151517214, createdName=shixen, createdTime=Sun Sep 10 07:11:08 CST 2023, time=2023-09-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2020-05-01 741040263_45099105

中了呢临床设计 2020-03-16 00:00:00 发表:
我投了一篇，第二天就是under review了

临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了

3170 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138685, encodeId=ce862138685a0, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：Stroke 经验分享：卒中学顶级期刊，官网称15天左右给出第一决定，从递交到正式接受约140天，50%的投稿被直接Desk Reject，最终的接受率约10%，含金量极高的杂志，国人投稿比例居于第三，相对友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue May 23 22:21:18 CST 2023, time=2023-05-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=568794, encodeId=d16b568e9482, content=投了一篇meta，要求润色，请问润色后被接受的概率大吗？可以自己润色不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1832, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=222a2577847, createdName=2018b066_47191297, createdTime=Fri Mar 29 10:35:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201537, encodeId=6fd2220153e81, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿一个月后给的返修建议。想问下有没有人在修稿时加过作者啊？想咨询一下流程~顺便想问下所有作者确认的邮件链是啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42ae8186426, createdName=ms7000001088510634, createdTime=Fri May 03 08:55:41 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156952, encodeId=35d321569521c, content=审稿速度:1.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af151517214, createdName=shixen, createdTime=Sun Sep 10 07:11:08 CST 2023, time=2023-09-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2023-05-23 ms5000000540226119 来自江苏省

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：Stroke
经验分享：卒中学顶级期刊，官网称15天左右给出第一决定，从递交到正式接受约140天，50%的投稿被直接Desk Reject，最终的接受率约10%，含金量极高的杂志，国人投稿比例居于第三，相对友好

175 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138685, encodeId=ce862138685a0, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：Stroke 经验分享：卒中学顶级期刊，官网称15天左右给出第一决定，从递交到正式接受约140天，50%的投稿被直接Desk Reject，最终的接受率约10%，含金量极高的杂志，国人投稿比例居于第三，相对友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue May 23 22:21:18 CST 2023, time=2023-05-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=568794, encodeId=d16b568e9482, content=投了一篇meta，要求润色，请问润色后被接受的概率大吗？可以自己润色不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1832, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=222a2577847, createdName=2018b066_47191297, createdTime=Fri Mar 29 10:35:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201537, encodeId=6fd2220153e81, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿一个月后给的返修建议。想问下有没有人在修稿时加过作者啊？想咨询一下流程~顺便想问下所有作者确认的邮件链是啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42ae8186426, createdName=ms7000001088510634, createdTime=Fri May 03 08:55:41 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156952, encodeId=35d321569521c, content=审稿速度:1.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af151517214, createdName=shixen, createdTime=Sun Sep 10 07:11:08 CST 2023, time=2023-09-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2019-03-29 2018b066_47191297

投了一篇meta，要求润色，请问润色后被接受的概率大吗？可以自己润色不？

1832 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138685, encodeId=ce862138685a0, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：Stroke 经验分享：卒中学顶级期刊，官网称15天左右给出第一决定，从递交到正式接受约140天，50%的投稿被直接Desk Reject，最终的接受率约10%，含金量极高的杂志，国人投稿比例居于第三，相对友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue May 23 22:21:18 CST 2023, time=2023-05-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=568794, encodeId=d16b568e9482, content=投了一篇meta，要求润色，请问润色后被接受的概率大吗？可以自己润色不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1832, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=222a2577847, createdName=2018b066_47191297, createdTime=Fri Mar 29 10:35:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201537, encodeId=6fd2220153e81, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿一个月后给的返修建议。想问下有没有人在修稿时加过作者啊？想咨询一下流程~顺便想问下所有作者确认的邮件链是啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42ae8186426, createdName=ms7000001088510634, createdTime=Fri May 03 08:55:41 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156952, encodeId=35d321569521c, content=审稿速度:1.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af151517214, createdName=shixen, createdTime=Sun Sep 10 07:11:08 CST 2023, time=2023-09-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2021-06-08 医学生的成长

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向： Stroke
经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些

1065 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138685, encodeId=ce862138685a0, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：Stroke 经验分享：卒中学顶级期刊，官网称15天左右给出第一决定，从递交到正式接受约140天，50%的投稿被直接Desk Reject，最终的接受率约10%，含金量极高的杂志，国人投稿比例居于第三，相对友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue May 23 22:21:18 CST 2023, time=2023-05-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=568794, encodeId=d16b568e9482, content=投了一篇meta，要求润色，请问润色后被接受的概率大吗？可以自己润色不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1832, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=222a2577847, createdName=2018b066_47191297, createdTime=Fri Mar 29 10:35:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201537, encodeId=6fd2220153e81, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿一个月后给的返修建议。想问下有没有人在修稿时加过作者啊？想咨询一下流程~顺便想问下所有作者确认的邮件链是啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42ae8186426, createdName=ms7000001088510634, createdTime=Fri May 03 08:55:41 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156952, encodeId=35d321569521c, content=审稿速度:1.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af151517214, createdName=shixen, createdTime=Sun Sep 10 07:11:08 CST 2023, time=2023-09-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2018-10-25 weilinjie

外审了，被录用的机率多大

455 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138685, encodeId=ce862138685a0, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：Stroke 经验分享：卒中学顶级期刊，官网称15天左右给出第一决定，从递交到正式接受约140天，50%的投稿被直接Desk Reject，最终的接受率约10%，含金量极高的杂志，国人投稿比例居于第三，相对友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue May 23 22:21:18 CST 2023, time=2023-05-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=568794, encodeId=d16b568e9482, content=投了一篇meta，要求润色，请问润色后被接受的概率大吗？可以自己润色不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1832, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=222a2577847, createdName=2018b066_47191297, createdTime=Fri Mar 29 10:35:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201537, encodeId=6fd2220153e81, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿一个月后给的返修建议。想问下有没有人在修稿时加过作者啊？想咨询一下流程~顺便想问下所有作者确认的邮件链是啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42ae8186426, createdName=ms7000001088510634, createdTime=Fri May 03 08:55:41 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156952, encodeId=35d321569521c, content=审稿速度:1.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af151517214, createdName=shixen, createdTime=Sun Sep 10 07:11:08 CST 2023, time=2023-09-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2019-11-13 ms5624929764890046

很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。

267 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138685, encodeId=ce862138685a0, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：Stroke 经验分享：卒中学顶级期刊，官网称15天左右给出第一决定，从递交到正式接受约140天，50%的投稿被直接Desk Reject，最终的接受率约10%，含金量极高的杂志，国人投稿比例居于第三，相对友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue May 23 22:21:18 CST 2023, time=2023-05-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=568794, encodeId=d16b568e9482, content=投了一篇meta，要求润色，请问润色后被接受的概率大吗？可以自己润色不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1832, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=222a2577847, createdName=2018b066_47191297, createdTime=Fri Mar 29 10:35:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201537, encodeId=6fd2220153e81, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿一个月后给的返修建议。想问下有没有人在修稿时加过作者啊？想咨询一下流程~顺便想问下所有作者确认的邮件链是啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42ae8186426, createdName=ms7000001088510634, createdTime=Fri May 03 08:55:41 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156952, encodeId=35d321569521c, content=审稿速度:1.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af151517214, createdName=shixen, createdTime=Sun Sep 10 07:11:08 CST 2023, time=2023-09-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2024-05-03 ms7000001088510634 来自江苏省

审稿速度:1.0 | 投稿命中率:75.0
经验分享：投稿一个月后给的返修建议。想问下有没有人在修稿时加过作者啊？想咨询一下流程~顺便想问下所有作者确认的邮件链是啥意思啊

7 0

[GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138685, encodeId=ce862138685a0, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：Stroke 经验分享：卒中学顶级期刊，官网称15天左右给出第一决定，从递交到正式接受约140天，50%的投稿被直接Desk Reject，最终的接受率约10%，含金量极高的杂志，国人投稿比例居于第三，相对友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue May 23 22:21:18 CST 2023, time=2023-05-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=568794, encodeId=d16b568e9482, content=投了一篇meta，要求润色，请问润色后被接受的概率大吗？可以自己润色不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1832, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=222a2577847, createdName=2018b066_47191297, createdTime=Fri Mar 29 10:35:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201537, encodeId=6fd2220153e81, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿一个月后给的返修建议。想问下有没有人在修稿时加过作者啊？想咨询一下流程~顺便想问下所有作者确认的邮件链是啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42ae8186426, createdName=ms7000001088510634, createdTime=Fri May 03 08:55:41 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156952, encodeId=35d321569521c, content=审稿速度:1.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af151517214, createdName=shixen, createdTime=Sun Sep 10 07:11:08 CST 2023, time=2023-09-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2023-09-10 shixen 来自北京

审稿速度:1.0
经验分享：可以

128 0

[GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138685, encodeId=ce862138685a0, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：Stroke 经验分享：卒中学顶级期刊，官网称15天左右给出第一决定，从递交到正式接受约140天，50%的投稿被直接Desk Reject，最终的接受率约10%，含金量极高的杂志，国人投稿比例居于第三，相对友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue May 23 22:21:18 CST 2023, time=2023-05-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=568794, encodeId=d16b568e9482, content=投了一篇meta，要求润色，请问润色后被接受的概率大吗？可以自己润色不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1832, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=222a2577847, createdName=2018b066_47191297, createdTime=Fri Mar 29 10:35:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201537, encodeId=6fd2220153e81, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿一个月后给的返修建议。想问下有没有人在修稿时加过作者啊？想咨询一下流程~顺便想问下所有作者确认的邮件链是啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42ae8186426, createdName=ms7000001088510634, createdTime=Fri May 03 08:55:41 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156952, encodeId=35d321569521c, content=审稿速度:1.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af151517214, createdName=shixen, createdTime=Sun Sep 10 07:11:08 CST 2023, time=2023-09-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2021-11-29 14612008m08(暂无昵称)

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：脑卒中
经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿

2153 0

[GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138685, encodeId=ce862138685a0, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：Stroke 经验分享：卒中学顶级期刊，官网称15天左右给出第一决定，从递交到正式接受约140天，50%的投稿被直接Desk Reject，最终的接受率约10%，含金量极高的杂志，国人投稿比例居于第三，相对友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue May 23 22:21:18 CST 2023, time=2023-05-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=568794, encodeId=d16b568e9482, content=投了一篇meta，要求润色，请问润色后被接受的概率大吗？可以自己润色不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1832, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=222a2577847, createdName=2018b066_47191297, createdTime=Fri Mar 29 10:35:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201537, encodeId=6fd2220153e81, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿一个月后给的返修建议。想问下有没有人在修稿时加过作者啊？想咨询一下流程~顺便想问下所有作者确认的邮件链是啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42ae8186426, createdName=ms7000001088510634, createdTime=Fri May 03 08:55:41 CST 2024, time=2024-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156952, encodeId=35d321569521c, content=审稿速度:1.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af151517214, createdName=shixen, createdTime=Sun Sep 10 07:11:08 CST 2023, time=2023-09-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2021-10-23 ms3000001635648837

偏重的研究方向：Stroke;脑缺血
经验分享：2天就被拒了，不耽误事

773 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务